Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.40 |
| ▸ | LOX | P28300 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | JAK3 | P52333 | 1/20 | 0.36 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.35 |
| ▸ | FEN1 | P39748 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA4 | P22748 | 2/20 | 0.34 |
| ▸ | CA6 | P23280 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29644921 | 1.00 | BCAT2 (0.40) | BCAT2LOXDRD2HSD11B1JAK2 | |
| SCHEMBL7269139 | 0.98 | BCAT2 (0.39) | BCAT2LOXDRD2HSD11B1JAK2 | |
| SCHEMBL7262689 | 0.84 | BCAT2 (0.33) | BCAT2LOXJAK2JAK3PTK2 | |
| SCHEMBL8106699 | 0.81 | LOX (0.47) | BCAT2LOXDRD2HSD11B1GAA | |
| SCHEMBL3279998 | 0.79 | GAA (0.50) | GAACA1CA2CA4CA6 | |
| SCHEMBL30948577 | 0.79 | GAA (0.50) | GAACA1CA2CA4CA6 | |
| SCHEMBL27996869 | 0.76 | PSIP1 (0.48) | HSD11B1GAAALOX5APFEN1ADRA2A | |
| SCHEMBL4613245 | 0.75 | ALDH1A1 (0.44) | GAACA1CA2CA4CA6 | |
| SCHEMBL1048970 | 0.75 | TSHR (0.44) | GAACA1CA2CA4CA6 | |
| SCHEMBL1806991 | 0.75 | CA2 (0.56) | GAACA1CA2CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114728935-A | SHP2 inhibitor | IRBM股份公司 | 2022-07-08 | — | — | CN | disclosed |
| EP-2563123-B1 | NOVEL BETA 3 ADRENERGIC RECEPTOR AGONISTS | MERCK SHARP & DOHME (US) | 2018-04-25 | — | — | EP | disclosed |
| US-8987516-B2 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
| CN-101663268-B | Method for preparing aryl sulfur pentafluoride | UBE INDUSTRIES | 2014-12-24 | — | — | CN | disclosed |
| EP-2468722-B1 | Process for producing arylsulfur halotetrafluorides | UBE INDUSTRIES (JP) | 2014-10-01 | — | — | EP | disclosed |
| EP-2468721-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2014-02-26 | — | — | EP | disclosed |
| US-20140018537-A1 | GPR119 AGONIST | NIPPON CHEMIPHAR CO., LTD. (JP) | 2014-01-16 | — | — | US | disclosed |
| EP-2468720-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-11-27 | — | — | EP | disclosed |
| EP-2468719-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-10-16 | — | — | EP | disclosed |
| US-8536176-B2 | GPR119 agonist | NIPPON CHEMIPHAR CO., LTD. (JP) | 2013-09-17 | — | — | US | disclosed |
| WO-2004106302-A1 | NOVEL SUBSTITUTED 3-SULFUR INDOLES | ASTRAZENECA AB (SE) | 2004-12-09 | — | — | WO | disclosed |
| US-20030220524-A1 | Sulfur containing compounds | LANGLER RICHARD FRANCIS (CA) | 2003-11-27 | — | — | US | disclosed |
| EP-1259482-A2 | SULFUR CONTAINING COMPOUNDS | University Health Network (CA) | 2002-11-27 | — | — | EP | disclosed |
| WO-2001062668-A2 | SULFUR CONTAINING COMPOUNDS | UNIVERSITY HEALTH NETWORK (CA) | 2001-08-30 | — | — | WO | disclosed |
| EP-0451007-B1 | Sulphonylphenyl-beta-D-thioxylosides, process for their preparation and their use in therapy | FOURNIER IND & SANTE (FR) | 1995-11-08 | — | — | EP | disclosed |
| US-5296579-A | From (hydro)sulfide, polyhalogenated aromatic compound and a mercaptan | PHILLIPS PETROLEUM COMPANY (US) | 1994-03-22 | — | — | US | disclosed |
| US-5100913-A | Venous antithrombotics | FOURNIER INDUSTRIE ET SANTE (FR) | 1992-03-31 | — | — | US | disclosed |
| EP-0451007-A1 | Sulphonylphenyl-beta-D-thioxylosides, process for their preparation and their use in therapy | FOURNIER INDUSTRIE ET SANTE (FR) | 1991-10-09 | — | — | EP | disclosed |
| US-4192829-A | INSECTICIDES, MITICIDES, NEMATOCIDES | EXXON RESEARCH & ENGINEERING CO. (US) | 1980-03-11 | — | — | US | disclosed |
| US-4075332-A | Pesticidal O,S'-dialkyl S-hydrocarbylthioalkyl dithiophosphates and oxidized derivatives thereof | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220524-A1 | Sulfur containing compounds | SQOR, MCL1, NDUFS5 | BCAT2 1844/4885LOX 2621/4885DRD2 4248/4885 |
| US-20140018537-A1 | GPR119 AGONIST | GPR119, GPR27, GPR52 | BCAT2 1831/4885LOX 3740/4885DRD2 182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.